Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 96-101 , 30 October 2009

Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression

  • Islam A. Saleh

      Affiliations

    • Center of Excellence for Aging and Brain Repair, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Theresa Zesiewicz

      Affiliations

    • Department of Neurology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Yong Xie

      Affiliations

    • Center of Excellence for Aging and Brain Repair, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Kelly L. Sullivan

      Affiliations

    • Department of Neurology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Amber M. Miller

      Affiliations

    • Department of Neurology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Nicole Kuzmin-Nichols

      Affiliations

    • Saneron CCEL Therapeutics, Inc., Tampa, FL 33612, United States
    • ,
  • Paul R. Sanberg

      Affiliations

    • Center of Excellence for Aging and Brain Repair, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Neurosurgery, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Molecular Pharmacology and Physiology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Pathology and Cell Biology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Psychiatry, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • ,
  • Svitlana Garbuzova-Davis

      Affiliations

    • Center of Excellence for Aging and Brain Repair, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Neurosurgery, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Molecular Pharmacology and Physiology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Department of Pathology and Cell Biology, University of South Florida, College of Medicine, Tampa, FL 33612, United States
    • Corresponding Author InformationCorresponding author. Center of Excellence for Aging and Brain Repair Department of Neurosurgery University of South Florida, College of Medicine 12901 Bruce B. Downs Blvd. Tampa, FL 33612, United States. Tel.: +1 813 974 3189; fax: +1 813 974 3078.

Received 22 January 2009 ,Revised 19 July 2009 ,Accepted 21 July 2009.

References 

  1. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57:1282–1289
  2. Apostolski S, Nikolić J, Bugarski-Prokopljević C, Miletić V, Pavlović S, Filipović S. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 1991;83:96–98
  3. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch. Neurol. 1986;43:234–238
  4. Bartfeld H, Dham C, Donnenfeld H, Jashnani L, Carp R, Kascsak R, et al. Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens. Clin. Exp. Immunol. 1982;48:137–146
  5. Bartfeld H, Dham C, Donnenfeld H. Immunoregulatory and activated T cells in amyotrophic lateral sclerosis patients. J. Neuroimmunol. 1985;9:131–137
  6. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J. Neurol. Sci. 1994;124:96–107Suppl
  7. Brooks BR, Miller RG, Swash M, Munsat TL World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293–299
  8. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J. Neurol. Sci. 1999;169:13–21
  9. Chia D, Barnett EV, Yamagata J, Knutson D, Restivo C, Furst D. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG). Clin. Exp. Immunol. 1979;37:399–407
  10. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806–819
  11. Cooper KM, Moore M. Critical aspects of immune complex assays employing polyethylene glycol. J. Immunol. Methods. 1983;60:289–302
  12. Donnenfeld H, Kascsak RJ, Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 1984;6:51–57
  13. Edwards JC, Cambridge G, Abrahams VM. Do self-perpetuating B lymphocytes drive human autoimmune disease?. Immunology. 1999;97:188–196
  14. Engelhardt JL, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 1990;47:1210–1216
  15. Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 1993;50:30–36
  16. Engelhardt JI, Soós J, Obál I, Vigh L, Siklós L. Subcellular localization of IgG from the sera of ALS patients in the nervous system. Acta Neurol. Scand. 2005;112:126–133
  17. Fiszman ML, Borodinsky LN, Ricart KC, Sanz OP, Sica RE. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 1999;162:34–37
  18. Goodall EF, Morrison KE. Amyotrophic lateral sclerosis motor neuron disease: proposed mechanisms and pathways to treatment. Expert. Rev. Mol. Med. 2006;8:1–22
  19. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–719
  20. Holmøy T. T cells in amyotrophic lateral sclerosis. Eur. J. Neurol. 2008;15:360–366
  21. Ingham KC. Precipitation of proteins with polyethylene glycol. Methods Enzymol. 1990;182:301–306
  22. Kávai M, Lukács K, Sonkoly I, Pálóczi K, Szegedi G. Circulating immune complexes and monocyte Fc function in autoimmune diseases. Ann. Rheum. Dis. 1979;38:79–83
  23. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 1992;140:691–707
  24. Latifynia A, Vojgani M, Abofazeli T, Jafarieh H. Circulating immune complex during Ramadan. J. Ayub. Med. Coll. Abbottabad. 2007;19:15–18
  25. Lederer CW, Santama N. Amyotrophic lateral sclerosis — the tools of the trait. Biotechnol. J. 2007;2:608–621
  26. Manger BJ, Krapf FE, Gramatzki M, Nüsslein HG, Burmester GR, Krauledat PB, et al. IgE-containing circulating immune complexes in Churg–Strauss vasculitis. Scand. J. Immunol. 1985;21:369–373
  27. McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459–470
  28. Noronha AB, Antel JP, Roos RP, Medof ME. Circulating immune complexes in neurologic disease. Neurology. 1981;31:1402–1407
  29. Oldstone MB, Wilson CB, Perrin LH, Norris FH. Evidence for immune-complex formation in patients with amyotrophic lateral sclerosis. Lancet. 1976;2:169–172
  30. Pramatarova A, Figlewicz DA, Krizus A, Han FY, Ceballos-Picot I, Nicole A, et al. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 1995;56:592–596
  31. Provinciali L, Laurenzi MA, Vesprini L, Giovagnoli AR, Bartocci C, Montroni M, et al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol. Scand. 1988;78:449–454
  32. Rahman A, Isenberg DA. Systemic lupus erythematosus. N. Engl. J. Med. 2008;358:929–939
  33. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62
  34. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. New Engl. J. Med. 2001;344:1688–1700
  35. Soltis RD, Hasz DE. The effect of serum immunoglobulin concentration on immune complex detection by polyethylene glycol. J. Immunol. Methods. 1983;57:275–282
  36. Tachovsky TG, Lisak RP, Koprowski H, Theofilopoulos AN, Dixon FJ. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet. 1976;2:997–999
  37. Troost D, Van Den Oord JJ, Vianney de Jong JM. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. J. Neuropathol. Appl. Neurobiol. 1990;16:410-410
  38. Tsai JF, Tsai JH, Chang WY, Ton TC. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest. 1991;9:137–143
  39. van der Giessen M, The TH. Characterization of the soluble immune complexes that are detected by three different techniques. Clin. Immunol. Immunopathol. 1986;38:244–255
  40. Westarp ME, Bartmann P, Kornhuber HH. Immunoglobulin-G isotype changes in human sporadic amyotrophic lateral sclerosis (ALS). Neurosci. Lett. 1994;173:124–126
  41. Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 2005;159:215–224
  42. Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Lancero M, et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 2006;179:87–93

PII: S0165-5728(09)00293-8

doi: 10.1016/j.jneuroim.2009.07.011

Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 96-101 , 30 October 2009

Article Tools

* Image Usage & Resolution